News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
218 Results
Type
Article (14)
Company Profile (1)
Press Release (203)
Section
Business (83)
Career Advice (1)
Deals (9)
Drug Development (34)
FDA (4)
Job Trends (32)
News (118)
Policy (2)
Tag
Alliances (8)
Approvals (4)
Best Places to Work (35)
Cancer (2)
Career advice (1)
Cell therapy (1)
Clinical research (32)
Data (5)
Earnings (44)
Events (50)
Executive appointments (3)
FDA (4)
Funding (1)
Government (1)
Healthcare (34)
IPO (9)
Job search strategy (1)
Lung cancer (1)
Manufacturing (1)
Mergers & acquisitions (1)
NextGen: Class of 2025 (1)
Now hiring (2)
Patient recruitment (1)
People (39)
Pharmaceutical (1)
Phase I (20)
Phase II (23)
Phase III (1)
Pipeline (3)
Preclinical (2)
Rare diseases (1)
Regulatory (1)
Series B (1)
Sickle cell disease (1)
Vaccines (6)
Date
Last 30 days (2)
Last 365 days (22)
2025 (18)
2024 (39)
2023 (54)
2022 (51)
2021 (40)
2020 (16)
Location
Asia (6)
Australia (1)
California (31)
Europe (5)
Massachusetts (1)
Northern California (24)
Southern California (3)
United States (33)
Washington State (1)
218 Results for "vaxcyte".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxcyte to Establish Fill-Finish Manufacturing in North Carolina as Key Element of Long-Term United States Commercial Supply Strategy Representing Up to $1 Billion in Manufacturing and Services
October 1, 2025
·
4 min read
Press Releases
Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose
September 3, 2025
·
10 min read
Press Releases
Vaxcyte Appoints Dr. Olivier Brandicourt to Board of Directors
May 2, 2025
·
6 min read
Press Releases
Vaxcyte Reports First Quarter 2025 Financial Results and Provides Business Update
May 8, 2025
·
14 min read
Press Releases
Vaxcyte Reports Second Quarter 2025 Financial Results and Provides Business Update, Highlighting Key Clinical and Regulatory Progress for VAX-31, a Potential Best-in-Class Pneumococcal Conjugate Vaccine (PCV)
August 7, 2025
·
15 min read
Press Releases
Vaxcyte to Present at the Guggenheim SMID Cap Biotech Conference
January 31, 2025
·
2 min read
Press Releases
Vaxcyte Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study
April 1, 2025
·
14 min read
Press Releases
Vaxcyte to Host Webcast and Conference Call to Present Topline Results from VAX-24 Infant Phase 2 Study
March 31, 2025
·
2 min read
Press Releases
Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 25, 2025
·
18 min read
Press Releases
Vaxcyte to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025
February 12, 2025
·
2 min read
1 of 22
Next
